Your browser doesn't support javascript.
loading
Novel risk models for early detection and screening of ovarian cancer.
Russell, Matthew R; D'Amato, Alfonsina; Graham, Ciaren; Crosbie, Emma J; Gentry-Maharaj, Aleksandra; Ryan, Andy; Kalsi, Jatinderpal K; Fourkala, Evangelia-Ourania; Dive, Caroline; Walker, Michael; Whetton, Anthony D; Menon, Usha; Jacobs, Ian; Graham, Robert L J.
Afiliación
  • Russell MR; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • D'Amato A; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Graham C; School of Healthcare Science, Manchester Metropolitan University, UK.
  • Crosbie EJ; Gynaecological Oncology Research Group, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Gentry-Maharaj A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Ryan A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Kalsi JK; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Fourkala EO; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Walker M; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Whetton AD; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Menon U; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Jacobs I; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Graham RL; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Oncotarget ; 8(1): 785-797, 2017 Jan 03.
Article en En | MEDLINE | ID: mdl-27903971
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Modelos Estadísticos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Modelos Estadísticos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos